These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 88237

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME, McKee PA.
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
    Stel HV, Sakariassen KS, Scholte BJ, Veerman EC, van der Kwast TH, de Groot PG, Sixma JJ, van Mourik JA.
    Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay.
    Kopitsky RG, Switzer ME, McKee PA.
    Thromb Haemost; 1982 Apr 30; 47(2):145-9. PubMed ID: 6213066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO, Sanders JC, Eyster ME.
    Thromb Haemost; 1981 Feb 23; 45(1):68-72. PubMed ID: 6166064
    [Abstract] [Full Text] [Related]

  • 9. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME, Gordon HJ, McKee PA.
    Biochemistry; 1983 Mar 15; 22(6):1437-44. PubMed ID: 6188490
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
    Saenko EL, Shima M, Gilbert GE, Scandella D.
    J Biol Chem; 1996 Nov 01; 271(44):27424-31. PubMed ID: 8910322
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Autoantibody to factor VIII that has less reactivity to factor VIII/von Willebrand factor complex.
    Amano K, Arai M, Koshihara K, Suzuki T, Kagawa K, Nishida Y, Fukutake K.
    Am J Hematol; 1995 Aug 01; 49(4):310-7. PubMed ID: 7639276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor.
    Aly AM, Hoyer LW.
    J Clin Invest; 1992 May 01; 89(5):1382-7. PubMed ID: 1569181
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K, Nogami K, Shima M.
    Br J Haematol; 2013 Oct 01; 163(1):104-11. PubMed ID: 23889549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.